What type of study is this?

This is a Systematic Review study.

September 16, 2025Frontiers in OncologyOpen Access

A synthetic cohort analysis of postoperative management of primary cardiac angiosarcoma and a case report

View Full Paper

Ask AI

Bookmark

Patients receiving postoperative adjuvant therapy exhibited significantly better overall survival compared to those who did not.
Median overall survival was 14 months in the adjuvant therapy group, contrasting with 8 months in the non-treated group.
The analysis utilized data from a systematic review and survival analysis, confirming the impact of adjuvant therapy.
Findings indicate that further research is required to strengthen recommendations for the management of primary cardiac angiosarcoma.

No takes yet. Share an insight, caveat, or question.

Systematic review reveals that adjuvant therapy significantly enhances postoperative outcomes in primary cardiac angiosarcoma patients.

Cai et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark